Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Type, Mode of Delivery & End-User The global coronary stents market will witness a robust CAGR of 4.78%, valued at $8.56 billion in 2021, expected to appreciate and reach $13.03 billion by 2030, confirms Strategic Market Research. Coronary stents are flexible mesh tubes inserted into the arteries to substantially improve the overall blood flow process and prevent the heart muscles from further damage. It is widely implemented during a surgical procedure to keep the arteries open and effectively prevent them from getting blood clogged. According to World Health Organisation, cardiovascular diseases are one of the leading causes of mortality, resulting in up to 18 million deaths each year, thus resulting in approximately 32.43% of the total number of deaths worldwide. Furthermore, one-third of these deaths occur among people under 70 years of age. Therefore, the continuous rising prevalence of cardiovascular diseases (CVDs), such as heart attack and stroke, together with the growing geriatric population, is guaranteed to propel the growth of the Coronary Stent Market during the forecasted period. COVID-19 Impact The COVID-19 outbreak had a considerable impact on the overall market growth rate. This deadly pandemic has led to a substantial rise in myocardial infarction affecting the overall cardiovascular system, especially of the elderly population who were victims of the Covid-19 outbreak. During this period, there is an utmost need for a conservative approach for patients with acute cardiovascular diseases. The invention of some efficient antiproliferative drugs and polymers for controlling, releasing, and allowing adequate endothelialization along with the optimal duration of the antiplatelet regimen will drastically boost the entire market growth amidst the pandemic. Market Drivers: - The high increase in the rate of cardiovascular diseases such as stroke and heart attacks, and the continuous rising of the senior population worldwide, are the two main reasons that are widely simulating the growth of this market. The widespread use of Alcohol, Tobacco, and Stress is also considered a pivotal contributor to heart ailments, thereby driving the market growth. The Spike in the number of percutaneous coronary intervention (PCI) methods over the last few years has also contributed immensely to the acceleration process of the overall market growth rate. Restraints: - In-stent restenosis (ISR) is the main reason that obstructs this market's growth as it results in gradual re-narrowing of the stented coronary artery lesion because of arterial damage with subsequent neointimal tissue proliferation. The occurrence of in-stent restenosis (ISR) remains an intimidating challenge despite several advancements in coronary intervention technology. Moreover, Angiographic Restonisis is also one of the major problems that have been reported in as many as 50% of the patients within six months of balloon angioplasty surgery. In addition, it has led to repeated target-vessel revascularization in (20-30)% of cardiac patients. Opportunities: - Coronary angioplasty with stenting is estimated to revolutionize the treatment of arterial diseases. Approximately 30% of patients across the globe will experience restenosis in the future, which can be successfully treated by implementing this highly upgraded and modernized technique. The new Bioresorbable Vascular Scaffold (BVS) is another widely adopted cardiac surgery method that is expected to witness a massive growth in the future. The overall BVS market is growing rapidly at a CAGR of 12.47%, with overall revenue of USD 210.78 Million in 2020. It is expected to gain a significant landmark of USD 539.7 Million in 2028. BVS provides adequate radial support for a long period to avoid early recoil and releases antiproliferative drugs to prevent restenosis. There has been a rising preference for minimally invasive surgeries (MIS), as it provides shorter hospital stays and facilitates a quick recovery, and this approach will gain substantial market growth in the future. MIS market is expanding steadily with an overall growth rate of 7.51% and is estimated to reach a value of USD 33.667 Billion in 2028. Coronary Stents Market Analysis Of Different Segments Covered in the Report Based on Type: Bare-Metal Stents Drug-Eluting Stents Bioabsorbable Stents Based on Mode of Delivery: Balloon-Expandable Stents Self-Expanding Stents Based on End-User: Hospitals Cardiac Centers Ambulatory Surgical Centers (ASCs) Regional Coverage Analysis North America US Canada Mexico Rest of North America Europe Germany France U.K Netherlands Switzerland Finland Belgium Russia Italy Spain Turkey Rest of Europe Asia Pacific China Japan India South Korea Singapore Malaysia Australia Thailand Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Segments Analysis & Insights Based on the type, the 'Drug-Eluting Stents (DES)' held the most dominant share as of 2020, with an overall value of USD 6.95 Billion and growing at a CAGR of 8.77%. Factors such as an abrupt increase in adopting a sedentary lifestyle that led to atherosclerosis effectively enhance the Drug-Eluting Stents segment. Moreover, the widespread use of Drug-Eluting Stents (DES) in the geriatric population will lower the risk of restenosis, which is one of the pivotal factors driving this market's growth significantly. The Bare metal stent is a kind of stent that does not carry any coating or covering. It consists of a mesh-like tube with a thin wire, and the formation of a bare metal stent seems a metallic coil generally made up of stainless steel, cobalt chromium alloy, or other costly metals. Bare metal surgeries do not incorporate the incisions approach and are usually executed under local anesthesia. On the foundation of the product, the bare metal stent market is divided into balloon catheters, metallic stents, expendable stents, and self-expendable. North America dictates the bare metal stent market owing to rising lifestyle resulting in obesity and cardiovascular diseases, namely ischemic heart diseases (IHD), heart attack, and stroke. The soaring prevalence of coronary artery diseases after the expansion in the number of PCI procedures and rising demand for minimally invasive approaches in this region leads to the overall growth of the market. The worldwide PTA balloon catheter (Percutaneous Transluminal Angioplasty) market size was estimated and projected at USD 2.6 billion in 2021 & is forecasted at a CAGR of 9.92% from 2022-2030. In 2021, North America dictated the global market with a revenue share of 35%. This can be credited to the favorable remuneration policies and key manufacturers. A study published in health affairs found that prices of stent metal varied significantly in the U.S. compared to Germany. The U.S. pays six times more than Germany for cardiac implants, based on the data collected from 2006-2014. More than 2 Mn people get a stent placed each year, with 1 million people belonging to America. The global drug-eluting stent (DES) market size was estimated at USD 6.5 billion in 2021 & is projected to reach USD 9.58 billion by 2026, displaying a CAGR of 6.6% during the estimated period. A drug-eluting stent is a semi-stiff, tube-like device built of metal and coated with a drug. The drug is steadily released to prevent restenosis or reappearance of the arterial blockage. According to National Centre for Health Statistics, 1 in 4 deaths in the U.S. is an outcome of coronary artery disease (CAD). In 2017, Nearly 18.2 million adults aged 20 years and above in the United States suffered and had CAD. As per the European Heart Network (EHN), in 2015, approximately 11.3 million new cases of patients suffering from Cardiovascular diseases were detected in Europe. The rising prevalence of coronary artery diseases and rising health spending in developing countries will boost the growth of stents in the global market. The rise of peripheral arterial disease (PAD) is another attribute expected to drive the Drug-Eluting Stent Market growth. As asserted by the National Center for Chronic Disease Prevention & Health Promotion, nearly 8.5 million people aged 40 years and above in the United States are enduring PAD. In the U.S., DES price range between $950 and $1200, whereas in India, the same DES price is almost double. Based on the Mode of Delivery, the 'Balloon-Expandable Stents' segment is expected to dominate the market during the forecasted period owing to the higher rate of stent utilization and an increase in research activities for further improvement of this technology, and growing regulatory approvals. Based on End Users, the 'Hospitals' segment is estimated to dominate the market owing to the effective and efficient utilization of coronary stents in hospitals. It also lacks well-planned referral networks for responding effectively and efficiently to the population's health needs. For patients without health insurance, the hospital expenditure on coronary stents ranges typically between USD 11,000 to USD 41,000, depending on the type of stent and the length of hospital stay. Regional Analysis & Insights North America has the most dominant regional market for coronary stents as of 2020 and is estimated to witness the same trend throughout the foreseeable future. Every year, about 647,000 people in the United States die from heart disease, thus making it one of the leading causes of death. One out of every four deaths occurs due to cardiac diseases. According to WHO, Cardiovascular diseases resulted in the death of almost 30.47 million people in the United States in 2018. A sedentary lifestyle results have led to obesity and other cardiovascular diseases such as stroke, heart attack, and ischemic heart diseases (IHD), which are driving the market growth of the U.S. Coronary Stent. Also, major innovative techniques in coronary stent technologies, such as the usage of biodegradable materials, and bifurcated stents, have further augmented the overall market growth in the United States. Asia Pacific is the fastest-growing region with the highest compound annual growth rate (CAGR) during the forecasted period. The mortality rate due to cardiac diseases is rising abruptly in this region. About one-third of the total deaths occur due to cardiovascular diseases. According to WHO, cardiac diseases caused more than 9.4 million deaths in 2016 in the APAC region. Factors like the growing prevalence of cardiac diseases, large population base, low manufacturing costs, and rising acceptance of advanced technologies are expected to drive market growth in this region. Moreover, the growing focus of key market leaders in this region is widely estimated to boost the coronary stents market immensely in the future. Coronary Stents Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 8.56 Billion The revenue forecast in 2030 USD 13.03 Billion Growth rate CAGR of approximately 4.78% The base year for estimation 2021 Historical data 2016 – 2019 Unit USD Billion, CAGR (2021 - 2028) Segmentation Based on Type, Based on Mode of Delivery, End-User, and Regions. Based on Type Bare-Metal Stents, Drug-Eluting Stents, Bioabsorbable Stents. Based on Mode of Delivery Balloon-Expandable Stents, Self-Expanding Stents. Based on End-User Hospitals, Cardiac Centers, Ambulatory Surgical Centers (ASCs). Based on Region North America, Europe, Asia Pacific, LAMIA. Country Scope U.S, Canada, France, Germany, U.K, China, Japan, India, South Korea, Mexico, Brazil, U.A.E. etc. Company Usability Profiles Medtronic plc, Biosensors International Group Limited, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Cook Medical, B. Braun Melsungen AG, Terumo Corporation, Vascular Concepts, STENTYS SA. MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd, Transluminal. Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Global Coronary Stents Market Competitive Landscape Analysis The competitive landscape analysis provides adequate details on the major competitors that are prevailing in the market environment. The comparison is performed based on the company overview, the overall potential of the market, investment in R&D, total revenue generated, market initiatives, company financials, strengths and weaknesses, production sites and facilities, production capacity, etc. Medtronic plc Biosensors International Group Limited Abbott Boston Scientific Corporation BIOTRONIK SE & Co. KG Cook Medical B. Braun Melsungen AG Terumo Corporation Vascular Concepts STENTYS SA MicroPort Scientific Corporation Meril Life Sciences Pvt. Ltd Translumina Recent Developments On August 2022, a group of scientists from Leesburg developed a highly efficient subtraction technique for the purpose of coronary-stent evaluation. It was discovered that this technique required the combination of DLR, i.e., deep learning reconstruction. This combination yielded highly efficient diagnostic performance for detecting stent restenosis by the coronary CTA. In 2018, Cook Medical received FDA approval for launching the first five mm diameter SFA drug-eluting stent. It is implemented for the treatment of vessels which are as small as 4mm in diameter. Also, it will provide an additional option in treating patients with lesions in their superficial femoral arteries (SFAs). On October 2021, Medtronic Resolute Onyx Drug-Eluting Stent was the first to receive One Month DAPT indication. The Resolute Onyx DES is the one, and only DES proved to be highly safe, effective, and reliable in the United States. Resolute Onyx DES, along with its biocompatible polymer and stent design, is highly effective for patients suffering from cardiac diseases. Frequently Asked Question About This Report How big is the coronary stents market? The global coronary stents market size was $8.56 Bn in 2021 and is predicted to reach $13.03 Bn by 2030, with a CAGR of 4.78%. Which segment accounted for the highest market share? North America significantly dominated the market with a share of 34.7% in 2020. This is attributed to the increasing prevalence of cardiovascular diseases like heart attack, stroke, ischemic heart diseases, and consumers increased focus for better and effective treatment. What are the different key factors that are driving the overall growth of the market? Major factors that are effectively and efficiently driving the market growth include the continuous rising prevalence of cardiovascular diseases (CVDs) such as heart attack and stroke, growing geriatric population, rising occurrence for minimally invasive surgeries (MIS), and a drastic increase in the number of PCI methods. What is the coronary stents market growth? The global coronary stents market is expected to grow at a compound annual growth rate (CAGR) of 4.78% from 2021 to 2030 to reach USD13.03 billion by 2030. Who all are the major companies involved in the global market? Some of the pivotal players in the market include Abbott, C. R. Bard Inc., Terumo Corporation, Medtronic, Boston Scientific, Cook Medical, and MicroPort Scientific Corporation. Sources https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583537/ https://health.costhelper.com/stents.html https://www.healthline.com/health/heart-disease/statistics https://www.who.int/health-topics/cardiovascular-diseases Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Market Segmentation 1.3.2 Geographic Scope Figure 02: Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Drug-Eluting Stents (DES) to Witness Highest CAGR in the Market, By Type, During Forecast Period Figure 11: Hospitals to Witness Higher CAGR in the Market for End-User Segment during Forecast Period Figure 12: Balloon-Expandable Stents for Mode of Delivery to Register Highest CAGR in the Market during Forecast Period Figure 13: North America to Account for Largest Share of Global Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 14: Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Coronary Stents Market 5.2.1 Global market, 2021 – 2030 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global market, by region, 2021-2030 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global market, by Type, 2021-2030 (USD Million) 5.5 End-User Analysis 5.5.1 Global market, by End-User, 2021-2030 (USD Million) 5.6 Usage Segment Analysis 5.6.1 Global market, by Mode of Delivery, 2021-2030 (USD Million) 5.7 By Usage Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 market PEST analysis 5.10.2 market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 16 Market Drivers and Their Impact 6.2.2 Restraints Figure 17 Market Restraints and Their Impact 6.2.3 Opportunities Figure 18 Market Opportunities and Their Impact 6.2.4 Challenges Figure 19 Market Challenges and Their Impact 6.3 Impact of Covid-19 on Market 6.4 Value Chain Analysis Figure 20 Value Chain Analysis: Market 6.5 Ecosystem Figure 21 Market: Ecosystem Table 3 Market: Ecosystem Figure 22 Revenue Shift in Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Market in USA in Last 9 Years Figure 23 Top 13 Companies with Highest No. of Patents in Last 9 Years Figure 24 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Market 6.7 Trade Analysis Figure 25 Import Data for Bare-Metal Stents, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Drug-Eluting Stents, By Country, 2016–2020 (USD Thousand) Figure 26 Import Data for Bioabsorbable Stents, By Country, 2016–2020 (USD Thousand) Figure 27 Export Data for Bare-Metal Stents, By Country, 2016–2020 (USD Thousand) Table 7 Export Data for Drug-Eluting Stents, By Country, 2016–2020 (USD Thousand) Figure 28 Export Data for Bioabsorbable Stents, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 9 Key Regulations: Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 29: Key players market share of companies 7.2 Manufacturers Manufacturing Sites, Area Served, Product Type 7.3 Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2021-2030) Table 11 Market, By Type, 2021–2028 (USD Million) Figure 30 Market, By Type Figure 31 Drug-Eluting Stents (DES) Segment to Register Highest CAGR in Market During Forecast Period 8.3 Drug-Eluting Stents (DES) 8.3.1 Drug-Eluting Stents (DES) market, 2021-2030 (USD Million) Figure 32: Drug-Eluting Stents (DES) market, 2021-2030 (USD Million) 8.4 Bare-Metal Stents 8.4.1 Bare-Metal Stents market, 2021-2030 (USD Million) Figure 33: Bare-Metal Stents market, 2021-2030 (USD Million) 8.5 Bioabsorbable Stents 8.5.1 Bioabsorbable Stents market, 2021-2030 (USD Million) Figure 34: Bioabsorbable Stents market, 2021-2030 (USD Million) Chapter 9. Global Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2021-2030) Table 12: Market, By End-User, 2021–2028 (USD Million) Figure 35: Market, By End-User, 2021–2028 (USD Million) Figure 36: Hospitals Segment to Register Highest CAGR in Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2021-2030 (USD Million) Figure 37: Hospitals market, 2021-2030 (USD Million) 9.4 Cardiac Centers 9.4.1 Cardiac Centers market, 2021-2030 (USD Million) Figure 38: Cardiac Centers market, 2021-2030 (USD Million) 9.5 Ambulatory Surgical Centers (ASCs) 9.5.1 Ambulatory Surgical Centers (ASCs) market, 2021-2030 (USD Million) Figure 39: Ambulatory Surgical Centers (ASCs) market, 2021-2030 (USD Million) Chapter 10. Global Market: Mode of Delivery Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2021-2030) Table 13: Market, By Mode of Delivery, 2021–2028 (USD Million) Figure 40: Market, By Mode of Delivery, 2021–2028 (USD Million) Figure 41: Balloon-Expandable Stents Segment to Register Highest CAGR in Market during Forecast Period 10.3 Balloon-Expandable Stents 10.3.1 Balloon-Expandable Stents market, 2021-2030 (USD Million) Figure 42: Balloon-Expandable Stents market, 2021-2030 (USD Million) 10.4 Self-Expanding Stents 10.4.1 Self-Expanding Stents market, 2021-2030 (USD Million) Figure 43: Self-Expanding Stents market, 2021-2030 (USD Million) Chapter 11. Global Market: Regional Outlook 11.1 North America Figure 44: North America Market, By Revenue Forecast (2021-2030) 11.1.1 North America market, by country, 2021-2030 (USD Million) Table 14: North America Market, by Country, 2021-2030 Figure 45: North America Market 11.1.2 North America market, by Type, 2021-2030 (USD Million) Table15: North America market, by Type, 2021-2030 (USD Million) Figure 46: North America market, by Type, 2021-2030 (USD Million) 11.1.3 North America market, by End-User, 2021-2030 (USD Million) Table 16: North America market, by End-User, 2021-2030 (USD Million) Figure 47: North America market, by End-User, 2021-2030 (USD Million) 11.1.4 North America market, by Mode of Delivery, 2021-2030 (USD Million) Table 17: North America market, by Mode of Delivery, 2021-2030 (USD Million) Figure 48: North America market, by Mode of Delivery, 2021-2030 (USD Million) 11.1.5 U.S. 11.1.5.1 U.S. market, by Type, 2021-2030 (USD Million) Figure 49: U.S. market, by Type, 2021-2030 (USD Million) 11.1.5.2 U.S. market, by End-User, 2021-2030 (USD Million) Figure 50: U.S. market, by End-User, 2021-2030 (USD Million) 11.1.5.3 U.S. market, by Mode of Delivery, 2021-2030 (USD Million) Figure 51: U.S. market, by Mode of Delivery, 2021-2030 (USD Million) 11.1.6 Canada 11.1.6.1 Canada market, by Type, 2021-2030 (USD Million) Figure 52: Canada market, by Type, 2021-2030 (USD Million) 11.1.6.2 Canada market, by End-User, 2021-2030 (USD Million) Figure 53: Canada market, by End-User, 2021-2030 (USD Million) 11.1.6.3 Canada market, by Mode of Delivery, 2021-2030 (USD Million) Figure 54: Canada market, by End-User, 2021-2030 (USD Million) 11.1.6.4 Canada market, by Mode of Delivery, 2021-2030 (USD Million) Figure 55: Canada market, by End-User, 2021-2030 (USD Million) 11.2 Europe Figure 56: Europe Market, By Revenue Forecast (2021-2030) 11.2.1 Europe market, by country, 2021-2030 (USD Million) Table 18: Europe market, by country, 2021-2030 (USD Million) Figure 57: Europe market, by country, 2021-2030 (USD Million) 11.2.2 Europe market, by Type, 2021-2030 (USD Million) Table 19: Europe market, by Type, 2021-2030 (USD Million) Figure 58: Europe market, by Type, 2021-2030 (USD Million) 11.2.3 Europe market, by End-User, 2021-2030 (USD Million) Table 20: Europe market, by End-User, 2021-2030 (USD Million) Figure 59: Europe market, by End-User, 2021-2030 (USD Million) 11.2.4 Europe market, by Mode of Delivery, 2021-2030 (USD Million) Table 21: Europe market, by Mode of Delivery, 2021-2030 (USD Million) Figure 60: Europe market, by Mode of Delivery, 2021-2030 (USD Million) 11.2.5 U.K. 11.2.5.1 U.K. market, by Type, 2021-2030 (USD Million) Figure 61: U.K. market, by Type, 2021-2030 (USD Million) 11.2.5.2 U.K. market, by End-User, 2021-2030 (USD Million) Figure 62: U.K. market, by End-User, 2021-2030 (USD Million) 11.2.5.3 U.K. market, by Mode of Delivery, 2021-2030 (USD Million) Figure 63: U.K. market, by Mode of Delivery, 2021-2030 (USD Million) 11.2.6 Germany 11.2.6.1 Germany market, by Type, 2021-2030 (USD Million) Figure 64: Germany market, by Type, 2021-2030 (USD Million) 11.2.6.2 Germany market, by End-User, 2021-2030 (USD Million) Figure 65: Germany market, by End-User, 2021-2030 (USD Million) 11.2.6.3 Germany market, by Mode of Delivery, 2021-2030 (USD Million) Figure 66: Germany market, by Mode of Delivery, 2021-2030 (USD Million) 11.2.7 France 11.2.7.1 France market, by Type, 2021-2030 (USD Million) Figure 67: France market, by Type, 2021-2030 (USD Million) 11.2.7.2 France market, by End-User, 2021-2030 (USD Million) Figure 68: France market, by End-User, 2021-2030 (USD Million) 11.2.7.3 France market, by Mode of Delivery, 2021-2030 (USD Million) Figure 69: France market, by Mode of Delivery, 2021-2030 (USD Million) 11.2.8 Rest of Europe 11.2.8.1 Rest of Europe market, by Type, 2021-2030 (USD Million) Figure 70: Rest of Europe market, by Type, 2021-2030 (USD Million) 11.2.8.2 Rest of Europe market, by End-User, 2021-2030 (USD Million) Figure 71: Rest of Europe market, by End-User, 2021-2030 (USD Million) 11.2.8.3 Rest of Europe market, by Mode of Delivery, 2021-2030 (USD Million) Figure 72: Rest of Europe market, by Mode of Delivery, 2021-2030 (USD Million) 11.3 Asia Pacific Figure 73: Asia Pacific Market, By Revenue Forecast (2021-2030) 11.3.1 Asia Pacific market, by country, 2021-2030 (USD Million) Table 22: Asia Pacific market, by country, 2021-2030 (USD Million) Figure 74: Asia Pacific market, by country, 2021-2030 (USD Million) 11.3.2 Asia Pacific market, by Type, 2021-2030 (USD Million) Table 23: Asia Pacific market, by Type, 2021-2030 (USD Million) Figure 75: Asia Pacific market, by Type, 2021-2030 (USD Million) 11.3.3 Asia Pacific market, by End-User, 2021-2030 (USD Million) Table 24: Asia Pacific market, by End-User, 2021-2030 (USD Million) Figure 76 Asia Pacific market, by End-User, 2021-2030 (USD Million) 11.3.4 Asia Pacific market, by Mode of Delivery, 2021-2030 (USD Million) Table 25: Asia Pacific market, by Mode of Delivery, 2021-2030 (USD Million) Figure 77: Asia Pacific market, by Mode of Delivery, 2021-2030 (USD Million) 11.3.5 China 11.3.5.1 China market, by Type, 2021-2030 (USD Million) Figure 78: China market, by Type, 2021-2030 (USD Million) 11.3.5.2 China market, by End-User, 2021-2030 (USD Million) Figure 79: China market, by End-User, 2021-2030 (USD Million) 11.3.5.3 China market, by Mode of Delivery, 2021-2030 (USD Million) Figure 80: China market, by Mode of Delivery, 2021-2030 (USD Million) 11.3.6 India 11.3.6.1 India market, by Type, 2021-2030 (USD Million) Figure 81: India market, by Type, 2021-2030 (USD Million) 11.3.6.2 India market, by End-User, 2021-2030 (USD Million) Figure 82: India market, by End-User, 2021-2030 (USD Million) 11.3.6.3 India market, by Mode of Delivery, 2021-2030 (USD Million) Figure 83: India market, by Mode of Delivery, 2021-2030 (USD Million) 11.3.7 Japan 11.3.7.1 Japan market, by Type, 2021-2030 (USD Million) Figure 84: Japan market, by Type, 2021-2030 (USD Million) 11.3.7.2 Japan market, by End-User, 2021-2030 (USD Million) Figure 85: Japan market, by End-User, 2021-2030 (USD Million) 12.3.7.3 Japan market, by Mode of Delivery, 2021-2030 (USD Million) Figure 86: Japan market, by Mode of Delivery, 2021-2030 (USD Million) 11.3.8 South Korea 11.3.8.1 South Korea market, by Type, 2021-2030 (USD Million) Figure 87: South Korea market, by Type, 2021-2030 (USD Million) 11.3.8.2 South Korea market, by End-User, 2021-2030 (USD Million) Figure 88: South Korea market, by End-User, 2021-2030 (USD Million) 12.3.8.3 South Korea market, by Mode of Delivery, 2021-2030 (USD Million) Figure 89: South Korea market, by Mode of Delivery, 2021-2030 (USD Million) 11.3.9 Rest of APAC 11.3.9.1 Rest of APAC market, by Type, 2021-2030 (USD Million) Figure 90 Rest of APAC market, by Type, 2021-2030 (USD Million) 11.3.9.2 Rest of APAC market, by End-User, 2021-2030 (USD Million) Figure 91: Rest of APAC market, by End-User, 2021-2030 (USD Million) 11.3.9.3 Rest of APAC market, by Mode of Delivery, 2021-2030 (USD Million) Figure 92: Rest of APAC market, by Mode of Delivery, 2021-2030 (USD Million) 11.4 Latin America Figure 93: Latin America Market, By Revenue Forecast (2021-2030) 11.4.1 Latin America market, by country, 2021-2030 (USD Million) Table 26: Latin America market, by country, 2021-2030 (USD Million) Figure 94: Latin America market, by country, 2021-2030 (USD Million) 11.4.2 Latin America market, by Type, 2021-2030 (USD Million) Table 27: Latin America market, by Type, 2021-2030 (USD Million) Figure 95: Latin America market, by Type, 2021-2030 (USD Million) 11.4.3 Latin America market, by End-User, 2021-2030 (USD Million) Table 28: Latin America market, by End-User, 2021-2030 (USD Million) Figure 96: Latin America market, by End-User, 2021-2030 (USD Million) 11.4.4 Latin America market, by Mode of Delivery, 2021-2030 (USD Million) Table 29: Latin America market, by Mode of Delivery, 2021-2030 (USD Million) Figure 97: Latin America market, by Mode of Delivery, 2021-2030 (USD Million) 11.4.5 Brazil 11.4.5.1 Brazil market, by Type, 2021-2030 (USD Million) Figure 98: Brazil market, by Type, 2021-2030 (USD Million) 11.4.5.2 Brazil market, by End-User, 2021-2030 (USD Million) Figure 99: Brazil market, by End-User, 2021-2030 (USD Million) 11.4.5.3 Brazil market, by Mode of Delivery, 2021-2030 (USD Million) Figure 100: Brazil market, by Mode of Delivery, 2021-2030 (USD Million) 11.4.6 Mexico 11.4.6.1 Mexico market, by Type, 2021-2030 (USD Million) Figure 101: Mexico market, by Type, 2021-2030 (USD Million) 11.4.6 2 Mexico market, by End-User, 2021-2030 (USD Million) Figure 102: Mexico market, by End-User, 2021-2030 (USD Million) 11.4.6.3 Mexico market, by Mode of Delivery, 2021-2030 (USD Million) Figure 103: Mexico market, by Mode of Delivery, 2021-2030 (USD Million) 11.4.7 Rest of the Latin America 11.4.7.1 Rest of the Latin America market, by Type, 2021-2030 (USD Million) Figure 104: Rest of the Latin America market, by Type, 2021-2030 (USD Million) 11.4.7.2 Rest of the Latin America market, by End-User, 2021-2030 (USD Million) Figure 105: Rest of the Latin America market, by End-User, 2021-2030 (USD Million) 11.4.7.3 Rest of the Latin America market, by Mode of Delivery, 2021-2030 (USD Million) Figure 106: Rest of the Latin America market, by Mode of Delivery, 2021-2030 (USD Million) 11.5 MEA Figure 107: MEA Market, By Revenue Forecast (2021-2030) 11.5.1 MEA market, by Type, 2021-2030 (USD Million) Figure 108: MEA market, by Type, 2021-2030 (USD Million) 11.5.2 MEA market, by End-User, 2021-2030 (USD Million) Figure 109: MEA market, by End-User, 2021-2030 (USD Million) 11.5.3 MEA market, by Mode of Delivery, 2021-2030 (USD Million) Figure 110: MEA market, by Mode of Delivery, 2021-2030 (USD Million) Chapter 12. Competitive Landscape 12.1 Medtronic plc. 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 Biosensors International Group Limited. 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 Abbott. 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 Boston Scientific Corporation. 12.4.1 Company overview 12.4.2 Financial performance 12.4.3 Product Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 BIOTRONIK SE & Co. KG. 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 Cook Medical. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 B. Braun Melsungen AG. 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 Terumo Corporation. 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 Vascular Concepts. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 STENTYS SA. 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Portfolio Analysis 12.10.4 Business Strategy & Recent Development 12.11 MicroPort Scientific Corporation. 12.11.1 Company overview 12.11.2 Financial performance 12.11.3 Product Portfolio Analysis 12.11.4 Business Strategy & Recent Development 12.12 Meril Life Sciences Pvt. Ltd. 12.12.1 Company overview 12.12.2 Financial performance 12.12.3 Product Portfolio Analysis 12.12.4 Business Strategy & Recent Development 12.13 Translumina. 12.13.1 Company overview 12.13.2 Financial performance 12.13.3 Product Portfolio Analysis 12.13.4 Business Strategy & Recent Development